Clinical trial
Phase I Double Blind Placebo Controlled Safety Study of ex Vivo Treatment of Kidneys From Deceased Donors With Renaparin®, Followed by Transplantation to Study Population
NCT03773211 is registered in ClinicalTrials.gov with Corline Biomedical AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Double Blind Placebo Controlled Safety Study of ex Vivo Treatment of Kidneys From Deceased Donors With Renaparin®, Followed by Transplantation to Study Population
- Lead sponsor
- Corline Biomedical AB
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 14, 2019
- Completion date
- April 21, 2020
- Enrollment
- 16 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.